CDKN2A and cervical cancer: This pan- European study was performed to estimate the sensitivity and specificity of the p16/Ki-67 dual-stained cytology and to compare it with Pap cytology testing in a routine European cervical cancer screening population of women 18 years or older, and to HPV testing in women 30 years or older.